N-(4-Hydroxyphenyl)retinamide (4-HPR), a retinoic acid analog, induces apop
tosis in several cell types. The mechanism by which 4-HPR initiates apoptos
is remains poorly understood. We examined the effects of 4-HPR on two prost
ate carcinoma cell lines, LNCaP (an androgen-sensitive, p53(+/+) cell line)
and PC-3 (an androgen-insensitive, p53(+/+) cell line). 4-HPR caused susta
ined c-Jun N-terminal kinase (JNK) activation and apoptosis in LNCaP cells
but not in PC-3 cells at the dosages tested. Activation of JNK by 4-HPR was
independent of caspases because a pan-caspase inhibitor failed to suppress
JNK activation. Ultraviolet-C and gamma-radiation induced JNK activation i
n both LNCaP and PC-3 cells, suggesting that the failure of PC-3 cells to r
espond to 4-HPR was due to defects upstream of the JNK pathway. Furthermore
, gamma-radiation-induced JNK activation was suppressed by an antioxidant,
but 4-HPR-induced JNK activation was not, indicating that these two stimuli
induced JNK activation through different mechanisms. Forced expression of
JNK1, but not a JNK1 mutant, caused apoptosis in both LNCaP and PC-3 cells,
suggesting that p53 is not required for JNK-mediated apoptosis. 4-HPR-indu
ced apoptosis in LNCaP cells was suppressed by curcumin, which inhibits JNK
activation. Expression of dominant-negative mutants in the JNK pathway als
o inhibited 4-HPR-induced apoptosis in human embryonic kidney 293 cells. Co
llectively, these results suggest that the JNK pathway mediates 4-HPR-induc
ed apoptotic signaling.